Retrieve available abstracts of 27 articles: HTML format
Single Articles
June 2025
GONG R, Huang B, Ralser A, Friedrich V, et al CagA-dependent Hobit(+) gastric tissue-resident memory T cells confer full
protection from Helicobacter pylori reinfection.
Gut. 2025 Jun 5:gutjnl-2025-334781. doi: 10.1136/gutjnl-2025-334781. PubMedAbstract available
May 2025
SHIN J, Cha B, Hong J, Kwon KS, et al Prevention of rebleeding after primary haemostasis using haemostatic powder in
non-variceal upper gastrointestinal bleeding: a multicentre randomised controlled
trial.
Gut. 2025 May 13:gutjnl-2024-332459. doi: 10.1136/gutjnl-2024-332459. PubMedAbstract available
April 2025
LEE YC Single-biopsy epigenetic profiling reveals persistent DNA methylation and gastric
cancer risk after Helicobacter pylori eradication.
Gut. 2025 Apr 23:gutjnl-2025-335329. doi: 10.1136/gutjnl-2025-335329. PubMed
October 2024
OLMEDO L, Calvet X, Gene E, Bordin DS, et al Evolution of the use, effectiveness and safety of bismuth-containing quadruple
therapy for Helicobacter pylori infection between 2013 and 2021: results from the
European registry on H. pylori management (Hp-EuReg).
Gut. 2024 Oct 26:gutjnl-2024-332804. doi: 10.1136/gutjnl-2024-332804. PubMedAbstract available
August 2024
LIU Z, Hong J, He F Letter to the editor: Autoimmune gastritis may be less susceptible to cancer
development than Helicobacter pylori-related gastritis based on histological
analysis.
Gut. 2024 Aug 29:gutjnl-2024-333604. doi: 10.1136/gutjnl-2024-333604. PubMed
July 2024
ZHANG Q, Dunbar KB, Odze RD, Agoston AT, et al Hypoxia-inducible factor-1alpha mediates reflux-induced epithelial-mesenchymal
plasticity in Barrett's oesophagus patients.
Gut. 2024;73:1269-1279. PubMedAbstract available
June 2024
GAO W, Liu J, Wang X, Li J, et al Simplified Helicobacter pylori therapy for patients with penicillin allergy: a
randomised controlled trial of vonoprazan-tetracycline dual therapy.
Gut. 2024 Jun 21:gutjnl-2024-332640. doi: 10.1136/gutjnl-2024-332640. PubMedAbstract available
May 2024
YUAN S, Larsson SC, Gill D, Burgess S, et al Concerns about instrumental variable selection for biological effect versus
uptake of proton pump inhibitors in Mendelian randomisation analysis.
Gut. 2024 May 2:gutjnl-2024-332280. doi: 10.1136/gutjnl-2024-332280. PubMed
April 2024
DUTTA AK, Sharma V, Jain A, Elhence A, et al Inappropriate use of proton pump inhibitors in clinical practice globally: a
systematic review and meta-analysis.
Gut. 2024 Apr 26:gutjnl-2024-332154. doi: 10.1136/gutjnl-2024-332154. PubMed
March 2024
BOECKXSTAENS G, Elsen S, Belmans A, Annese V, et al 10-year follow-up results of the European Achalasia Trial: a multicentre
randomised controlled trial comparing pneumatic dilation with laparoscopic Heller
myotomy.
Gut. 2024;73:582-589. PubMedAbstract available
February 2024
AN H, Zhong M, Gan H Proton pump inhibitors and the risk of inflammatory bowel disease: a Mendelian
randomisation study.
Gut. 2024 Feb 15:gutjnl-2024-331904. doi: 10.1136/gutjnl-2024-331904. PubMed
January 2024
XIAO X, Zhang X, Wang J, Liu Y, et al Proton pump inhibitors alter gut microbiota by promoting oral microbiota
translocation: a prospective interventional study.
Gut. 2024 Jan 24:gutjnl-2023-330883. doi: 10.1136/gutjnl-2023-330883. PubMed
BLACK CJ, Paine PA, Ford AC Letter to the editor: Helicobacter pylori eradication, the proof is not in the
symptoms-authors' reply.
Gut. 2024 Jan 12:gutjnl-2024-331892. doi: 10.1136/gutjnl-2024-331892. PubMed
December 2023
NARENDREN A, Tsoi AH, Iqbal A, Glance S, et al Rare complication of peptic ulcer disease.
Gut. 2023 Dec 12:gutjnl-2023-330867. doi: 10.1136/gutjnl-2023-330867. PubMed
TOH DE, Lo SW, Tsoi A, Segal JP, et al Right tool for the right bleeder.
Gut. 2023;73:206-207. PubMed
November 2023
ZHU J, Sun C, Li M, Hu G, et al Compared to histamine-2 receptor antagonist, proton pump inhibitor induces
stronger oral-to-gut microbial transmission and gut microbiome alterations: a
randomised controlled trial.
Gut. 2023 Nov 22:gutjnl-2023-330168. doi: 10.1136/gutjnl-2023-330168. PubMedAbstract available
LUO S, Ru J, Khan Mirzaei M, Xue J, et al Helicobacter pylori infection alters gut virome by expanding temperate phages
linked to increased risk of colorectal cancer.
Gut. 2023 Nov 2:gutjnl-2023-330362. doi: 10.1136/gutjnl-2023-330362. PubMed
September 2023
LIU BD, Udemba SC, Liang K, Tarabichi Y, et al Shorter-acting glucagon-like peptide-1 receptor agonists are associated with
increased development of gastro-oesophageal reflux disease and its complications
in patients with type 2 diabetes mellitus: a population-level retrospective
matched cohort st
Gut. 2023 Sep 22:gutjnl-2023-329651. doi: 10.1136/gutjnl-2023-329651. PubMedAbstract available
July 2023
Bismuth quadruple three-in-one single capsule three times a day increases
effectiveness compared with the usual four times a day schedule: results from the
European Registry on Helicobacter pylori Management (Hp-EuReg).
Gut. 2023 Jul 19:gutjnl-2022-329259. doi: 10.1136/gutjnl-2022-329259. PubMedAbstract available
June 2023
SJOMINA O, Vangravs R, Leonova E, Polaka I, et al Clarithromycin-containing triple therapy for Helicobacter pylori eradication is
inducing increased long-term resistant bacteria communities in the gut.
Gut. 2023 Jun 26:gutjnl-2023-329792. doi: 10.1136/gutjnl-2023-329792. PubMed
May 2023
ARAI J, Niikura R, Hayakawa Y, Hirata Y, et al Autoimmune gastritis may be less susceptible to cancer development than
Helicobacter pylori-related gastritis based on histological analysis.
Gut. 2023 May 17:gutjnl-2023-330052. doi: 10.1136/gutjnl-2023-330052. PubMed
LEI WY, Lee JY, Chuang SL, Bair MJ, et al Eradicating Helicobacter pylori via (13)C-urea breath screening to prevent
gastric cancer in indigenous communities: a population-based study and
development of a family index-case method.
Gut. 2023 May 17:gutjnl-2023-329871. doi: 10.1136/gutjnl-2023-329871. PubMedAbstract available
April 2023
RALSER A, Dietl A, Jarosch S, Engelsberger V, et al Helicobacter pylori promotes colorectal carcinogenesis by deregulating intestinal
immunity and inducing a mucus-degrading microbiota signature.
Gut. 2023 Apr 4:gutjnl-2022-328075. doi: 10.1136/gutjnl-2022-328075. PubMedAbstract available
YE BD Proton pump inhibitors and the risk of inflammatory bowel disease: cause,
protopathic bias or others?
Gut. 2023 Apr 4:gutjnl-2023-329506. doi: 10.1136/gutjnl-2023-329506. PubMed
March 2023
CHEN PY, Tsai FP, Chen MJ, Yang HY, et al Vonoprazan-based versus proton pump inhibitor-based therapy in Helicobacter
pylori eradication: an updated systematic review and meta-analysis of randomised
trials.
Gut. 2023 Mar 31:gutjnl-2023-329826. doi: 10.1136/gutjnl-2023-329826. PubMed
ZHANG J, Deng Y, Liu C, Wang H, et al 'Family-based' strategy for Helicobacter pylori infection screening: an efficient
alternative to 'test and treat' strategy.
Gut. 2023 Mar 7:gutjnl-2023-329696. doi: 10.1136/gutjnl-2023-329696. PubMed
MALFERTHEINER P, Megraud F, Rokkas T, Gisbert JP, et al Empiric use of standard triple therapy in Helicobacter pylori eradication does
not require readjustment in the clarithromycin resistance cut-off point.
Gut. 2023 Mar 6:gutjnl-2023-329712. doi: 10.1136/gutjnl-2023-329712. PubMed